This document is a publication of a new patent application filed with the USPTO, specifically application number US20260083828A1. The application, filed on September 11, 2025, by inventors Demetrios Braddock, Paul Stabach, and Ethan Lester, describes "Compositions and Methods for Treating, Ameliorating, and/or Preventing Diseases and/or Disorders" related to DNAse1 and/or DNAse1L3 deficiency.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on entities. However, it signifies potential future intellectual property rights and may inform research and development strategies in the biotechnology and pharmaceutical sectors. Companies operating in these areas should monitor the progress of this and similar patent applications to understand emerging therapeutic approaches and potential patent landscapes.